CAS 151213-15-9
:Acide 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylique
- 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
- 3-quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
- 6H-Pyrrolo[3,4-b]pyridine, 3-quinolinecarboxylic acid deriv.
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
- Moxifloxacin Imp. A RS IP
- Moxifloxacin hydrochloride impurity A
- Moxifloxacin Related CoMpound A
- Moxifloxacin impurity 1/Moxifloxacin EP Impurity A/Moxifloxacin Difluoro Analog/8-Desmethoxy-8-Fluoro Moxifloxacin/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- Moxifloxacin Related Matter 1
- Moxifloxacin impurity A
- 1-cyclopropyl-6-fluoro-7-amino-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-7-amino-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- USP/EP/BP
- Moxifloxacin EP Impurity A : Moxifloxacin Impurity A
- 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
- Moxifloxacin EP IMpurity A
- Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
- 8-Desmethoxy-8-fluoro Moxifloxacin
- 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1
- Moxifloxacin Hydrochloride IMpurity-A(EP)(USPRC A)
- Moxifloxacin IMp. A (EP,BP)
- 8-Ddesmethoxy-8-fluoroMoxifloxacin
- 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- Moxifloxacin EP Impurity A HCl USP/EP/BP
- Moxifloxacin EP Impurity A/ Moxifloxacin Related Compound A (Moxifloxacin Difluoro Analog)
- 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-d
- Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
- Moxifloxacin related substance A
- USP Moxifloxacin Related Compound A
- Moxifloxacin impurity 2/Moxifloxacin EP Impurity A HCl/Moxifloxacin Difluoro Analog HCl/8-Desmethoxy-8-fluoro Moxifloxacin HCl/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Hydrochloride
- Moxifloxacin Related Matter A
- Mosisasin ImpurityA
- Voir plus de synonymes
Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C20H21F2N3O3Couleur et forme :White Off-White PowderMasse moléculaire :389.43-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
CAS :Formule :C20H21F2N3O3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :389.3958Moxifloxacin EP Impurity A HCl (Moxifloxacin USP Related Compound A HCl)
CAS :Formule :C20H21F2N3O3·HClCouleur et forme :Pale Yellow SolidMasse moléculaire :389.40 36.461-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS :1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidDegré de pureté :95%Masse moléculaire :389.4g/mol8-Desmethoxy-8-fluoro Moxifloxacin
CAS :Impurity Moxifloaxacin EP Impurity A
Stability Hygroscopic
Applications 8-Desmethoxy-8-fluoro Moxifloxacin (Moxifloaxacin EP Impurity A) is an impurity of Moxifloxacin (M745000).
References Martel, A., et al.: Drugs Fut., 22, 109 (1997), Tobin, C., et al.: J. Antimicrob. Chemother., 42, 278 (1998),Formule :C20H21F2N3O3Couleur et forme :NeatMasse moléculaire :389.41-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS :Formule :C20H21F2N3O3Degré de pureté :95%Masse moléculaire :389.4038-Desmethoxy-8-fluoro moxifloxacin
CAS :8-Desmethoxy-8-fluoro moxifloxacin is a photolytic drug that is used to treat bacterial infections. It has a high degree of antibacterial activity against methicillin-resistant staphylococcus aureus, including methicillin resistant strains of Staphylococcus epidermidis. 8-Desmethoxy-8-fluoro moxifloxacin hydrochloride is produced by the addition of hydrochloric acid to moxifloxacin, which is then purified by ion chromatography. The compound has been shown to have good stability in human plasma and urine. It also shows excellent recoveries in acetonitrile and quantification results in flow rates.
Formule :C20H21F2N3O3Degré de pureté :Min. 95%Masse moléculaire :389.4 g/mol









